As we progress through 2026, the clinical narrative for Mounjaro in Dubai has expanded far beyond the scope of weight loss. While shedding excess pounds remains a primary goal for many, the true medical value of this dual-agonist therapy lies in its ability to resolve life-threatening comorbidities. Recent landmark studies, including the SURMOUNT-OSA trials published in early 2026, have...

The evolution of obesity medicine has been marked by numerous attempts to develop safe, effective interventions that address the biological complexity of weight regulation. For patients in the UAE who have experienced the frustration of repeated weight loss attempts followed by inevitable regain, Mounjaro in Dubai represents a scientifically validated breakthrough that targets the...